TYA research: the current research landscape and the treatment opportunities of the future



This study day will provide an overview of the research developments and opportunities surrounding TYA cancer care. We will discuss pioneering TYA clinical trials and tumour banking for TYA patients amongst other topical factors.

Topics will include:

  • Current clinical trials and the upcoming ALL trial
  • Tumour banking
  • Fertility
  • Patient perspective

Suitable for all researchers and healthcare professionals with an interest in TYA research as well as those working in primary or secondary care working where TYAs may present and colleagues working within paediatrics.

The PAXMAN Scalp Cooling System, developed by the Paxman family reduces chemotherapy-induced alopecia (CIA) in cancer patients. The concept came when mother of 4, Sue Paxman, experienced first-hand the trauma of CIA. Now the world’s leading manufacturer and supplier of scalp cooling equipment, PAXMAN have close to 4,000 systems installed worldwide.

Paxman are passionate about ensuring that every eligible person has access to scalp cooling. To ensure all UK teenagers and young adults are offered pioneering scalp cooling treatment – with no cost or administrative burden to the patient, hospital or Trust, Paxman and The Laura Crane Youth Cancer Trust (LCYCT) have a Teenage and Young Adult (TYA) service which allows the UK’s 28 specialist units access to scalp cooling.

Whenever a teenager or young adult is eligible for scalp cooling, PAXMAN will provide a concierge service direct to their TYA unit.

A proven way of combatting CIA, scalp cooling can result in a high level of retention or completely preserve the hair. It has also been proven to improve hair regrowth following chemotherapy. For patients, this means the opportunity to regain some control, maintain privacy and encourage a positive attitude towards treatment.

Sign up to our education events mailing list to be kept up to date with this and future events

Last updated: October 2021